Hi Ali,
I am really sorry to hear that you have had the same problems with raised liver enzymes even with both 3rd generation TKIs.
Glivec/imatinib @ 100mg. - my thinking on this option is: if you are still in MR you could give this a short trial.
100mg imatinib is not an active dose in the majority of chronic phase CML patients with higher levels of Ph+ cells, but given your sensitive/responsive disease (and you might consider the STIM trial results of approx 40% responders for people in CMR for over 2 years (0.003% bcr/abl) then you could think of 100mg imatinib as a 'maintainance dose' for you and it is such a low dose that you might not suffer from the side effects you previously suffered with 400mg.
Interferon: I assume this will be interferon alpha? I have no experience of this drug but I know that it can cause horrendous side effects.
There is another form - pegylated interferon- which allows a much lower dose to be given. However, I am not sure this form is available here in the UK. I know that Prof. Hochhaus in Germany has been studying this as a maintainance therapy for those in MMR/CMR for some time now. Your should be able to find published results of these studies if you google the German CML clincal studies/ and or his name.
I know dasatinib is used in very low doses in some people with good results- but this is anecdotal.
At least you know you have very responsive disease-i.e it is controled by TKI therapy. It is the sensitivity of your liver that is the problem- and that is a problem that I have no answers for (other than complimentary therapy like Milk Thistle which might or might not be effective in your case)
Hope this helps,
Sandy